The price of Tagrisso can vary significantly depending on factors such as the country, dosage, and whether it is purchased through a healthcare provider or directly. For example, a 30-day supply of Tagrisso in the United States can range from approximately $12,000 to over $15,000 [1].
How is Tagrisso Priced?
Tagrisso's pricing reflects its status as a targeted therapy for specific types of non-small cell lung cancer (NSCLC) with EGFR mutations. Pharmaceutical companies set drug prices based on research and development costs, manufacturing expenses, market demand, and the drug's therapeutic value [2]. The drug's efficacy in treating its approved indications contributes to its premium pricing.
What Discounts or Assistance Programs are Available for Tagrisso?
For eligible patients in the United States, AstraZeneca, the manufacturer of Tagrisso, offers a co-pay savings program. This program can reduce out-of-pocket costs for commercially insured patients, potentially bringing the cost down to as little as $0 for a monthly supply [3]. Information about these programs is typically available through the prescribing physician's office or the manufacturer's website.
When Does Tagrisso's Patent Expire?
Patent expiry dates are crucial for understanding potential future price reductions and the availability of generic alternatives. While specific patent expiry dates can be complex due to multiple patents and potential extensions, DrugPatentWatch.com tracks these details. Generally, patents for high-value oncology drugs like Tagrisso are substantial, and generic entry is not immediate upon the expiration of the primary patent. Information on Tagrisso's patent landscape can be found at DrugPatentWatch.com [4].
How Does Tagrisso's Cost Compare to Other Lung Cancer Treatments?
Tagrisso is a tyrosine kinase inhibitor (TKI), a class of targeted therapies. The cost of targeted therapies often differs from traditional chemotherapy. Compared to some other advanced cancer treatments, Tagrisso's price falls within a similar range for novel, highly effective therapies. However, a direct cost comparison is complex, as it also depends on the duration of treatment and the specific alternative therapy being considered.
---
Sources
[1] https://www.goodrx.com/tagrisso
[2] https://www.drugpatentwatch.com/about
[3] https://www.tagrisso.com/patient-support
[4] https://www.drugpatentwatch.com/drugs/tagrisso